Sign in
4

Changes in Ownership

SPRUCE BIOSCIENCES, INC. Filed Acc 0001869391-26-000007

Interim Chief Medical Officer acquired 1,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ways Douglas Kirk · Interim Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-11 Exercise or conversion : show line 1 in the form +1,250 1,250 D

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2025-12-11 Grant or award : show line 2 in the form Restricted Stock Units +5,000 5,000 D
2025-12-11 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,250 3,750 D
2025-12-11 Grant or award : show line 4 in the form Stock Option (Right to Buy) +266 266 D
2025-12-11 Returned to the company : show line 5 in the form Stock Option (Right to Buy) −266 0 D
2025-12-11 Grant or award : show line 6 in the form Stock Option (Right to Buy) +400 400 D
2025-12-11 Returned to the company : show line 7 in the form Stock Option (Right to Buy) −400 0 D
Loading xslF345X05/form4-01212026_090131.xml…